VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+19.18%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$495M
AUM Growth
+$97.7M
(+25%)
Cap. Flow
+$66.3M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
75.85%
Holding
33
New
7
Increased
3
Reduced
4
Closed
4
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$73.9M |
| 2 |
KALA BIO
KALA
|
+$26.5M |
| 3 |
VRNA
Verona Pharma
VRNA
|
+$12.1M |
| 4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$11.2M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
+$9.05M |
Top Sells
| 1 |
Codexis
CDXS
|
+$14.9M |
| 2 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
+$7.41M |
| 3 |
Dynavax Technologies
DVAX
|
+$3.47M |
| 4 |
AKTX
Akari Therapeutics
AKTX
|
+$1.12M |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$258K |
Sector Composition
| 1 | Healthcare | 92.89% |
| 2 | Materials | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTX
26
Akari Therapeutics
AKTX
$25.1M
| $2.12M | 0.43% |
17,293
-9,099
| -34% | -$1.12M |
|
27
KalVista Pharmaceuticals
KALV
$746M
| $2.02M | 0.41% |
+300,325
| New | +$2.02M |
|
|
VIRX
28
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $970K | 0.2% |
14,286
| – | – |
|
|
SLNOW
29
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
| $112K | 0.02% |
+188,772
| New | +$112K |
|
|
30
Dynavax Technologies
DVAX
$1.14B
| – | – |
-359,827
| Closed | -$3.47M |
|
|
CAPNW
31
DELISTED
Capnia, Inc. Series A Warrant
CAPNW
| – | – |
-943,858
| Closed | -$159K |
|